SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056450
Filing Date
2021-11-12
Accepted
2021-11-12 07:15:02
Documents
69
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbio-10q_20210930.htm   iXBRL 10-Q 2264474
2 EX-10.1 cbio-ex101_8.htm EX-10.1 170395
3 EX-31.1 cbio-ex311_9.htm EX-31.1 14107
4 EX-31.2 cbio-ex312_10.htm EX-31.2 14115
5 EX-32.1 cbio-ex321_7.htm EX-32.1 9725
6 EX-32.2 cbio-ex322_6.htm EX-32.2 9731
7 GRAPHIC gcurumigxli3000001.jpg GRAPHIC 181642
  Complete submission text file 0001564590-21-056450.txt   7778753

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210930.xsd EX-101.SCH 49413
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbio-20210930_cal.xml EX-101.CAL 37907
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbio-20210930_def.xml EX-101.DEF 141811
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210930_lab.xml EX-101.LAB 354716
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210930_pre.xml EX-101.PRE 271172
13 EXTRACTED XBRL INSTANCE DOCUMENT cbio-10q_20210930_htm.xml XML 1236550
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51173 | Film No.: 211399523
SIC: 2834 Pharmaceutical Preparations